This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Refractive Surgery and Optive Compatibility Study

This study has been completed.
Information provided by:
Innovative Medical Identifier:
First received: May 2, 2007
Last updated: April 16, 2008
Last verified: April 2008
To assess the compatibility of Optive with refractive surgery (PRK and LASIK) post-operatively.

Condition Intervention Phase
Dry Eye Syndromes Drug: Optive Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Refractive Surgery and Optive Compatibility Study

Further study details as provided by Innovative Medical:

Primary Outcome Measures:
  • Assess compatibility [ Time Frame: 8 months ]

Secondary Outcome Measures:
  • comfort [ Time Frame: 8 months ]

Enrollment: 92
Study Start Date: May 2007
Study Completion Date: April 2008
Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1. Drug: Optive
Optive 30ml- (in the eye) Instill one in each eye twice daily starting one week after surgery


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Men and women 18 and over
  • Patients undergoing refractive surgery

Exclusion Criteria:

  • Concurrent ocular conditions or pathology that could affect patient's ability to complete study
  • Concurrent use of topical medications other than study medications
  • Use of systemic medications with ocular drying sequelae:

    • Antihistamines
    • Decongestants
    • Antispasmotics
    • Antidepressants
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00469157

United States, California
Fullerton, California, United States, 92831
Sponsors and Collaborators
Innovative Medical
Principal Investigator: Loren Rude, OD TLC
  More Information

Responsible Party: Loren Rude, OD, TLC Identifier: NCT00469157     History of Changes
Other Study ID Numbers: 5303
Study First Received: May 2, 2007
Last Updated: April 16, 2008

Keywords provided by Innovative Medical:
compatibility of Optive after PRK or LASIK

Additional relevant MeSH terms:
Dry Eye Syndromes
Keratoconjunctivitis Sicca
Lacrimal Apparatus Diseases
Eye Diseases
Conjunctival Diseases
Corneal Diseases processed this record on September 19, 2017